MENU

PolyNovo Limited posts first-half sales growth of 319%

The PolyNovo Limited (ASX: PNV) share price has remained flat on Monday as it announced its sales of NovoSorb BTM for the first half of the 2019 financial year of $3.75m. This is a 319% increase on the prior corresponding period.

With a market capitalisation of around $392 million, PolyNovo develops medical devices using its patented polymer technology. NovoSorb Biodegradable Temporising Matrix (BTM) technology can be used to close wounds incurred through trauma, burns, surgery or wounding. The claim is that NovoSorb provides better results than rival products or skin grafts.

PolyNovo restructured in 2014 and has since made NovoSorb its main focus. The technology has gradually been proving itself as sales have picked up and results have been positive. Today’s update affirms this thesis but may have been expected by the market, as the share price closed down 0.83% at 60 cents.

It’s worth noting that PolyNovo isn’t making a profit. While it incurred a $6.1m loss in the 2018 financial year, it also had 59% revenue growth. Biotechnology companies generally don’t make a profit until their product is properly commercialised, which PolyNovo is still in the process of.

PolyNovo shares have risen 10.2% in the last 12 months, compared to a return of -7.17% for the S&P ASX/200.

Motley Fool contributor Cale Kalinowski has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The 5 mining stocks we’re recommending in 2019…

For decades, Australian mining companies have minted money for individual investors like you and me. But if you believe the pundits and talking heads on TV, those days are long gone. Finito! Behind us forever…

We say nothing could be further from the truth. To earn the really massive returns, you’ve got to fish where others aren’t fishing—and the mining sector could be primed for a resurgence. That’s why top Motley Fool analysts just revealed their exciting new research on 5 ASX miners they believe could help you profit in 2019 and beyond…

Including:

The best way we see to play the global zinc shortage… Our #1 favourite large-cap miner (hint: it’s not BHP)… one early-stage gold miner we think could hit the motherlode… Plus two more surprising companies you probably haven’t heard of yet!

For free access to our brand-new research, simply click here or the link below. But be warned, this research is available free for a limited time only, and we reserve the right to withdraw it at any time.

Click here for your FREE report!